Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Challenges of Vaccine Development against Betacoronaviruses: Antibody Dependent Enhancement and Sendai Virus as a Possible Vaccine Vector
T. A. Zaichuk, Yury D. Nechipurenko, A. A. Adzhubey, et al.
Molecular Biology (2020) Vol. 54, Iss. 6, pp. 812-826
Open Access | Times Cited: 24

Showing 24 citing articles:

The Role of Acidosis in the Pathogenesis of Severe Forms of COVID-19
Yury D. Nechipurenko, Denis Semyonov, I. A. Lavrinenko, et al.
Biology (2021) Vol. 10, Iss. 9, pp. 852-852
Open Access | Times Cited: 62
An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages
Hamid Motamedi, Marzie Mahdizade Ari, Shirin Dashtbin, et al.
International Immunopharmacology (2021) Vol. 96, pp. 107763-107763
Open Access | Times Cited: 49
A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies
Gabriela Athziri Sánchez‐Zuno, Mónica Guadalupe Matuz-Flores, Guillermo González‐Estevez, et al.
International Journal of Immunopathology and Pharmacology (2021) Vol. 35
Open Access | Times Cited: 44
Th2 and Th17‐associated immunopathology following SARS‐CoV‐2 breakthrough infection in Spike‐vaccinated ACE2‐humanized mice
Tianyi Zhang, Nicholas Magazine, Michael C. McGee, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Open Access | Times Cited: 6
Change of Antigenic Determinants of SARS-CoV-2 Virus S-Protein as a Possible Cause of Antibody-Dependent Enhancement of Virus Infection and Cytokine Storm
Yu. D. Nechipurenko, Anastasia A. Anashkina, O. V. Matveeva
BIOPHYSICS (2020) Vol. 65, Iss. 4, pp. 703-709
Open Access | Times Cited: 28
Single-virus assay reveals membrane determinants and mechanistic features of Sendai virus binding
Amy Lam, Orville O. Kirkland, Papa Freduah Anderson, et al.
Biophysical Journal (2022) Vol. 121, Iss. 6, pp. 956-965
Open Access | Times Cited: 11
Efficacy of a live attenuated highly pathogenic PRRSV vaccine against a NADC30-like strain challenge: implications for ADE of PRRSV
Xinxin Chen, Xinyu Zhou, Tengda Guo, et al.
BMC Veterinary Research (2021) Vol. 17, Iss. 1
Open Access | Times Cited: 14
Analysis of the Development of Trends in the Current Epidemic Situation during Spread of the New SARS-CoV-2 Strains and Factors of their Regional Differentiation
A. Yu. Perevaryukha
BIOPHYSICS (2023) Vol. 68, Iss. 5, pp. 874-888
Closed Access | Times Cited: 5
Antibody-Dependent Enhancement with a Focus on SARS-CoV-2 and Anti-Glycan Antibodies
М. М. Зиганшина, Nadezhda Shilova, Е. О. Халтурина, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1584-1584
Open Access | Times Cited: 4
An Outline of Contributing Vaccine Technologies for SARS CoV2 Advancing in Clinical and Preclinical Phase-Trials
Sheikh Saba Naz, Iqra Munir
Recent Patents on Biotechnology (2022) Vol. 16, Iss. 2, pp. 122-143
Closed Access | Times Cited: 7
ERDRP-0519 inhibits feline coronavirus in vitro
Michele Camero, Gianvito Lanave, Cristiana Catella, et al.
BMC Veterinary Research (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 7
Hybrid Model of the Collapse of the Commercial Crab Paralithodes camtschaticus (Decapoda, Lithodidae) Population of the Kodiak Archipelago
A. Yu. Perevaryukha
BIOPHYSICS (2022) Vol. 67, Iss. 2, pp. 300-319
Open Access | Times Cited: 7
MutCov: A pipeline for evaluating the effect of mutations in spike protein on infectivity and antigenicity of SARS-CoV-2
Wenyang Zhou, Chang Xu, Meng Luo, et al.
Computers in Biology and Medicine (2022) Vol. 145, pp. 105509-105509
Open Access | Times Cited: 4
Various theranostics and immunization strategies based on nanotechnology against Covid-19 pandemic: An interdisciplinary view
Sujan Chatterjee, Snehasis Mishra, Kaustav Dutta Chowdhury, et al.
Life Sciences (2021) Vol. 278, pp. 119580-119580
Open Access | Times Cited: 5
COVID-19, Influenza, and Other Acute Respiratory Viral Infections: Etiology, Immunopathogenesis, Diagnosis, and Treatment. Part I. COVID-19 and Influenza
T. N. Ilyicheva, Netesov Sv, V. N. Gureyev
Molecular Genetics Microbiology and Virology (2022) Vol. 37, Iss. 1, pp. 1-9
Open Access | Times Cited: 3
Theoretical Explanation for the Rarity of Antibody-Dependent Enhancement of Infection (ADE) in COVID-19
Anna E. Boldova, Julia-Jessica D. Korobkin, Yury D. Nechipurenko, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11364-11364
Open Access | Times Cited: 3
Cytokine Storm in the Novel Coronavirus Infection and Methods of its Correction
А. В. Ершов, V. D. Surova, В. Т. Долгих, et al.
Antibiot Khimioter = Antibiotics and Chemotherapy (2021) Vol. 65, Iss. 11-12, pp. 27-37
Open Access | Times Cited: 4
COVID-19 variants as moving targets and how to stop them by glycoengineered whole-virus vaccines
Uri Galili
Virulence (2021) Vol. 12, Iss. 1, pp. 1717-1720
Open Access | Times Cited: 4
Th2 and Th17-Associated Immunopathology Following SARS-CoV-2 Breakthrough Infection in Spike-Vaccinated ACE2-humanized Mice
Tianyi Zhang, Nicholas Magazine, Michael C. McGee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Modification of the Spike Protein for Vaccines against Enveloped RNA Viruses
Andrei N. Vzorov, E. I. Samokhvalov, Victoria V Chebanenko, et al.
Molecular Biology (2021) Vol. 55, Iss. 4, pp. 538-547
Open Access | Times Cited: 2
COVID-19, influenza, and other acute respiratory viral infections: etiology, immunopathogenesis, diagnosis, and treatment. Part I. COVID-19 and influenza
T. N. Ilyicheva, Netesov Sv, V. N. Gureyev
Molecular Genetics Microbiology and Virology (Russian) (2022) Vol. 40, Iss. 1, pp. 3-3
Closed Access | Times Cited: 1
Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing IgG, IgA and cellular immune responses and can boost neutralizing antibody responses primed by an injected vaccine
Jacob Pitcovski, Nady Gruzdev, Anna Abzach, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
Intranasal vaccine against COVID-19 based on a recombinant variant of the Sendai virus (Paramyxoviridae: <i>Respirovirus</i>) strain Moscow
Gleb A. Kudrov, С. С. Зайнутдинов, А. А. Гражданцева, et al.
Problems of Virology (2023) Vol. 68, Iss. 3, pp. 215-227
Open Access
Pharmacological Agents for COVID-19 Patients
Donald W. Johnson, Randi Searcy, Beranton Whisenant
Springer eBooks (2021), pp. 151-166
Closed Access
Page 1

Scroll to top